Amorphex Therapeutics

Manufacturing · Massachusetts, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

1 Dundee Park Dr Ste 8, Andover, Massach...

Phone Number

(978) 475-4491

Revenue

<$5 Million

Industry

Manufacturing Business Services Research & Development Medical Devices & Equipment
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About Amorphex Therapeutics

Amorphex Therapeutics is focused on developing TODDD, a patented device designed to enhance ocular drug delivery for treating various ophthalmic diseases, including glaucoma. This innovative, soft device allows for continuous drug delivery to the eye, replacing traditional eye drop therapies that often lead to adherence issues and inadequate dosing. By providing a safe, non-invasive solution, TODDD aims to improve patient experiences and outcomes while minimizing side effects. The technology also opens avenues for treating conditions where conventional drops are ineffective, such as retinal diseases and myopia progression.Explore more
Popular SearchesAmorphex Therapeutics LLCAmorphexAmorphex Medical LLPAmore IncAmorphex Therapeutics Holdings IncSIC Code 38,384NAICS Code 33,339Show more

Amorphex Therapeutics Org Chart

PhoneEmail
EE
United States flag for contact location.

Vice President, Technology

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Amorphex Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Amorphex Therapeutics

Compare insights from companies similar to Amorphex Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Amorphex Therapeutics

<$5M
1-10
Private
-
2013
EE
Edward EllisVice President, Technology
$6M
11-50
Private
-
-
N/A
$5.1M
11-50
Private
$24.6M
2004
CB
Carolynne BornhutterTraining Director, Human Resources
<$5M
11-50
Private
-
-
WM
William McVicarExecutive Vice President & Scientific Chief & Officer
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2015
KW
Keith WebsterChief Scientific Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Amorphex Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Amorphex Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Amorphex Therapeutics.

Amorphex Therapeutics Tech Stack

A closer look at the technologies used by Amorphex Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding Amorphex Therapeutics

What is Amorphex Therapeutics's official website?
Amorphex Therapeutics's official website is www.amorphexusa.com
What is Amorphex Therapeutics's Revenue?
Amorphex Therapeutics's revenue is <$5 Million
What is Amorphex Therapeutics's SIC code?
Amorphex Therapeutics's SIC: 38,384
What is Amorphex Therapeutics's NAICS code?
Amorphex Therapeutics's NAICS: 33,339
How many employees does Amorphex Therapeutics have?
Amorphex Therapeutics has 1-10 employees
What industry does Amorphex Therapeutics belong to?
Amorphex Therapeutics is in the industry of: Manufacturing, Business Services, Research & Development
What is Amorphex Therapeutics competition?
Amorphex Therapeutics top competitors include: BioTheraVision, Inotek Pharmaceuticals, Dompé, Insite Vision
What technology does Amorphex Therapeutics use?
Some of the popular technologies that Amorphex Therapeutics uses are: Sentry, Microsoft 365, F5 BIG-IP Platform, Sectigo
How do I contact Amorphex Therapeutics?
Amorphex Therapeutics contact info: Phone number: (978) 475-4491 Website: www.amorphexusa.com
What does Amorphex Therapeutics do?

Amorphex Therapeutics is focused on developing TODDD, a patented device designed to enhance ocular drug delivery for treating various ophthalmic diseases, including glaucoma. This innovative, soft device allows for continuous drug delivery to the eye, replacing traditional eye drop therapies that often lead to adherence issues and inadequate dosing... . By providing a safe, non-invasive solution, TODDD aims to improve patient experiences and outcomes while minimizing side effects. The technology also opens avenues for treating conditions where conventional drops are ineffective, such as retinal diseases and myopia progression.Read More

Is Amorphex Therapeutics a public company?
Amorphex Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Amorphex Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.